CBIO stock - Catalyst Biosciences

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Fri 16'th Nov 2018

PERIOD 2018-08-17 - 2018-11-16
CHANGE 1.86%
PRICE $10.96
VOLUME
Buy
TREND
Sell

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Buy
Request Prediction
0.00%
Predict

Catalyst Biosciences Stock Analysis

Technical stock analysis for Fri 16'th Nov 2018

Buy candidate since 2018-11-15 Gain 1.86%
Shorts n/a
Cash n/a
Loans n/a
Beta 1.97
ROA -29.76

Catalyst Biosciences gained 1.86% in the last trading day, rising from $10.76 to $10.96 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has been going up and down for this period, and there has been a 1.01% gain for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 174 576 more shares were traded than the day before. In total, 262 352 shares bought and sold for approximately $2.88 million.

Trend

Catalyst Biosciences lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $11.25 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -3.02% during the next 3 months and, with 90% probability hold a price between $8.52 and $10.91 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. Catalyst Biosciences holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $10.65 and $10.14. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday November 14, 2018, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 68 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Catalyst Biosciences finds support from accumulated volume at $10.85.

Support: $10.85 Price: $10.96 Resistance: $11.01

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.84 between high and low, or 8.13%. For the last week, the stock has had a daily average volatility of 7.13%.

Our recommended stoploss: $10.45 (-4.66%) (This stock has high daily movements and this gives high risk. There is a buy signal from pivot bottom found 2 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

CBIO $10.96 $0.20(1.86%)
CBIO is up $0.20 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for CBIO based on the 1-3 month system that more than doubles the S&P 500.

Click here – the CBIO analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at


in partnership with